Literature DB >> 1642644

Effect of depolarizing agents on the Ca(2+)-independent and Ca(2+)-dependent release of [3H]GABA from sheep brain synaptosomes.

M S Santos1, R Rodriguez, A P Carvalho.   

Abstract

The purpose of the present study was to compare the effects of several depolarizing agents on both the membrane potential and on the release of [3H] gamma-aminobutyric acid (GABA) from sheep brain cortex synaptosomes. We examined the effects of KCl, 4-aminopyridine (4-AP), veratridine, ouabain and tetraphenylphosphonium cation (TPP+) on Ca(2+)-independent (carrier-mediated) and Ca(2+)-dependent (exocytotic) release. We found that, in the absence of Ca2+, KCl at 40 mM releases 7.57 +/- 0.65%, veratridine at 50 microM releases 45.85 +/- 2.48%, ouabain at 1 mM releases 8.62 +/- 0.93% and TPP+ at 1 mM releases 4.09 +/- 0.37% of the total accumulated neurotransmitter, provided that the external medium contains Na+. These are about the maximal values of release obtained with each depolarizing agent in a Na+ medium and in the absence of Ca2+. Replacing external Na+ with choline blocks the release observed in the presence of the depolarizing agents in the absence of Ca2+, and this divalent ion can increase [3H]GABA release only for K+ or 4-AP. Synaptosomal depolarization requires Na+ except for K+ depolarization. Furthermore, although Ca2+ stimulates the release of [3H]GABA due to K+ depolarization (13.56 +/- 0.44%) or due to 4-AP (4.26 +/- 0.51%), it inhibits the release due to the other depolarizing agents. The amount of [3H]GABA released by 4-AP in Na+ medium (4.26 +/- 0.51%) is similar to that induced by KCl in the presence of Ca2+ in the absence of Na+ (3.39 +/- 0.29%) which represents only exocytotic release. This suggests that the Ca(2+)-dependent exocytotic release of [3H]GABA can be specifically induced by 4-AP in a Na+ medium, or by KCl in the absence of Na+, as reported by us earlier. The observation that Ca2+ inhibits the Ca(2+)-independent release is of interest because it suggests that Ca2+ may modulate the release of cytoplasmic GABA probably by inhibiting the carrier-mediated release of GABA. It is of interest as to whether Ca2+ regulation depends on intracellular Ca2+.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642644     DOI: 10.1016/0006-2952(92)90013-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Effects of external pH variations on brain presynaptic sodium and calcium channels; repercussion on the evoked release of amino acid neurotransmitters.

Authors:  M Sitges; R M Rodríguez
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

2.  Characterization of melittin effects in synaptosomes.

Authors:  L González; V Nekrassov; A Castell; M Sitges
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

3.  Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes.

Authors:  M Kammerer; M P Rassner; T M Freiman; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

4.  GABA(A) autoreceptors enhance GABA release from human neocortex: towards a mechanism for high-frequency stimulation (HFS) in brain?

Authors:  Michela Mantovani; Andreas Moser; Carola A Haas; Josef Zentner; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

5.  Lipid peroxidation and aluminium effects on the cholinergic system in nerve terminals.

Authors:  F C Amador; M S Santos; C R Oliveira
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

6.  Transmitter self-regulation by extracellular glutamate in fresh human cortical slices.

Authors:  Katharina Prauss; Ramya Varatharajan; Kevin Joseph; Andreas Moser
Journal:  J Neural Transm (Vienna)       Date:  2014-07-10       Impact factor: 3.575

7.  Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes.

Authors:  B Brawek; M Löffler; A Weyerbrock; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-11       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.